BIOREGENX, INC. Selling, General and Administrative Expense
BIOREGENX, INC. (BRGX) reported Selling, General and Administrative Expense of $396.39 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-05-20
- BIOREGENX, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $396.39K, a 32.86% decline year-over-year.
- BIOREGENX, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $552.09K, a 70.46% decline year-over-year.
- BIOREGENX, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $432.54K, a 83.06% increase year-over-year.
- BIOREGENX, INC. selling, general and administrative expense for the quarter ending 2025-06-30 was $456.73K, a 67.31% decline year-over-year.
- BIOREGENX, INC. selling, general and administrative expense for fiscal 2025 was $2.01M, a 65.70% decline from fiscal 2024.
- BIOREGENX, INC. selling, general and administrative expense for fiscal 2024 was $5.85M, a 11.89% increase from fiscal 2023.
- BIOREGENX, INC. selling, general and administrative expense for fiscal 2023 was $5.23M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-03-31 | $396.39K 10-Q · filed 2026-05-20 | $948.48K derived: sum of 2 quarters · filed 2026-05-20 | $1.38M derived: sum of 3 quarters · filed 2026-05-20 | $1.84M derived: sum of 4 quarters · filed 2026-05-20 | ||
| 2025-12-31 | $552.09K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $984.63K derived: sum of 2 quarters · filed 2026-04-15 | $1.44M derived: sum of 3 quarters · filed 2026-04-15 | $2.01M 10-K · filed 2026-04-15 | ||
| 2025-09-30 | $432.54K 10-Q · filed 2025-11-14 | $889.27K derived: sum of 2 quarters · filed 2025-11-14 | $1.45M 10-Q · filed 2025-11-14 | $3.35M derived: sum of 4 quarters · filed 2026-05-20 | ||
| 2025-06-30 | $456.73K 10-Q · filed 2025-08-14 | $1.05M 10-Q · filed 2025-08-14 | $2.92M derived: sum of 3 quarters · filed 2026-05-20 | $3.15M derived: sum of 4 quarters · filed 2026-05-20 | ||
| 2025-03-31 | $590.37K 10-Q · filed 2026-05-20 | $2.46M derived: sum of 2 quarters · filed 2026-05-20 | $2.70M derived: sum of 3 quarters · filed 2026-05-20 | $4.09M derived: sum of 4 quarters · filed 2026-05-20 | ||
| 2024-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $2.11M derived: sum of 2 quarters · filed 2026-04-15 | $3.50M derived: sum of 3 quarters · filed 2026-04-15 | $5.85M 10-K · filed 2026-04-15 | ||
| 2024-09-30 | $236.28K 10-Q · filed 2025-11-14 | $1.63M derived: sum of 2 quarters · filed 2025-11-14 | $3.98M 10-Q · filed 2025-11-14 | $5.54M derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $1.40M 10-Q · filed 2025-08-14 | $835.00K 10-Q · filed 2024-10-09 | $4.81M 10-Q · filed 2025-08-14 | $3.75M 10-Q · filed 2024-10-09 | $5.30M derived: sum of 3 quarters · filed 2025-08-14 | $8.26M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $3.41M 10-Q · filed 2025-05-15 | $1.05M 10-Q/A · filed 2024-05-29 | $3.90M derived: sum of 2 quarters · filed 2025-05-15 | $6.87M derived: sum of 3 quarters · filed 2025-05-15 | $7.87M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $494.52K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-04-16 | $3.46M derived: sum of 2 quarters · filed 2025-04-16 | $4.46M derived: sum of 3 quarters · filed 2025-04-16 | $5.23M 10-K/A · filed 2025-04-16 | ||
| 2023-09-30 | $2.96M 10-Q · filed 2024-11-14 | $3.96M derived: sum of 2 quarters · filed 2024-11-14 | $4.73M 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $1.00M 10-Q · filed 2024-10-09 | $1.77M 10-Q · filed 2024-10-09 | ||||
| 2023-03-31 | $770.99K 10-Q/A · filed 2024-10-09 |